TrialClinical rheumatology2016

Acute kidney injury observed during phase 1 clinical trials of a novel xanthine oxidase/URAT1 dual inhibitor PF-06743649.

Pinky Dua et al.PubMed ↗Publisher ↗

No numbers read from the abstract.